The expression of syndecan-1, syndecan-4 and decorin in healthy human breast tissue during the menstrual cycle

Reproductive Biology and Endocrinology

Volumn 8, Issue , 2010, Pages

  Hallberg, Gunilla ^a   Andersson, Eva ^b   Naessén, Tord ^a   Ordeberg, Gunvor E ^b  

^a UPPSALA UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DECORIN; SYNDECAN 1; SYNDECAN 4; PROTEOGLYCAN; SCLEROPROTEIN; SDC1 PROTEIN, HUMAN; SDC4 PROTEIN, HUMAN;

ADULT; ARTICLE; BREAST; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; FOLLICULAR PHASE; GENE EXPRESSION; GENE LOCATION; HUMAN; HUMAN TISSUE; LUTEAL PHASE; MENSTRUAL CYCLE; NUCLEOTIDE SEQUENCE; NULLIPARA; PARITY; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; TISSUE SECTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; GENETICS; HEALTH; IMMUNOHISTOCHEMISTRY; MAMMARY GLAND; METABOLISM; NEEDLE BIOPSY; PATHOLOGY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; BIOPSY, FINE-NEEDLE; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GENE EXPRESSION; HEALTH; HUMANS; IMMUNOHISTOCHEMISTRY; MAMMARY GLANDS, HUMAN; MENSTRUAL CYCLE; PROTEOGLYCANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SYNDECAN-1; SYNDECAN-4; YOUNG ADULT;

EID: 77950830267     PISSN: None     EISSN: 14777827     Source Type: Journal    
DOI: 10.1186/1477-7827-8-35     Document Type: Article

References (26)

1. Ferguson JE, Schor AM, Howell A, Ferguson MW. Tenascin distribution in the normal human breast is altered during the menstrual cycle and in carcinoma. Differentiation 1990, 42(3):199-207. 10.1111/j.1432-0436.1990.tb00762.x, 1692795.
2. Eshchenko TY, Rykova VI, Chernakov AE, Sidorov SV, Grigorieva EV. Expression of different proteoglycans in human breast tumors. Biochemistry (Mosc) 2007, 72(9):1016-1020. 10.1134/S0006297907090143, 17922662.
3. Kauppila A. The use of oestrogens and progestin and the risk of breast cancer in post-menopausal women. Pharmacol Res 1995, 32(6):327. G.A. Colditz et al. N. Engl. J. Med. 1995; 332: 1589-93, 10.1016/S1043-6618(05)80035-0, 8736481.
4. Bernfield M, Gotte M, Park PW, Reizes O, Fitzgerald ML, Lincecum J, Zako M. Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 1999, 68:729-777. 10.1146/annurev.biochem.68.1.729, 10872465.
5. Reid SE, Murthy MS, Kaufman M, Scanlon EF. Endocrine and paracrine hormones in the promotion, progression and recurrence of breast cancer. Br J Surg 1996, 83(8):1037-1046. 10.1002/bjs.1800830805, 8869300.
6. Shekhar MP, Pauley R, Heppner G. Host microenvironment in breast cancer development: extracellular matrix-stromal cell contribution to neoplastic phenotype of epithelial cells in the breast. Breast Cancer Res 2003, 5(3):130-135. 10.1186/bcr580, 164997, 12793893.
7. Barbareschi M, Maisonneuve P, Aldovini D, Cangi MG, Pecciarini L, Angelo Mauri F, Veronese S, Caffo O, Lucenti A, Palma PD, et al. High syndecan-1 expression in breast carcinoma is related to an aggressive phenotype and to poorer prognosis. Cancer 2003, 98(3):474-483. 10.1002/cncr.11515, 12879463.
8. Baba F, Swartz K, van Buren R, Eickhoff J, Zhang Y, Wolberg W, Friedl A. Syndecan-1 and syndecan-4 are overexpressed in an estrogen receptor-negative, highly proliferative breast carcinoma subtype. Breast Cancer Res Treat 2006, 98(1):91-98. 10.1007/s10549-005-9135-2, 16636895.
9. Troup S, Njue C, Kliewer EV, Parisien M, Roskelley C, Chakravarti S, Roughley PJ, Murphy LC, Watson PH. Reduced expression of the small leucine-rich proteoglycans, lumican, and decorin is associated with poor outcome in node-negative invasive breast cancer. Clin Cancer Res 2003, 9(1):207-214.
10. Reed CC, Waterhouse A, Kirby S, Kay P, Owens RT, McQuillan DJ, Iozzo RV. Decorin prevents metastatic spreading of breast cancer. Oncogene 2005, 24(6):1104-1110. 10.1038/sj.onc.1208329, 15690056.
11. Lundstrom E, Sahlin L, Skoog L, Hagerstrom T, Svane G, Azavedo E, Sandelin K, von Schoultz B. Expression of Syndecan-1 in histologically normal breast tissue from postmenopausal women with breast cancer according to mammographic density. Climacteric 2006, 9(4):277-282. 10.1080/13697130600865741, 16857657.
12. Lofgren L, Sahlin L, Jiang S, Von Schoultz B, Fernstad R, Skoog L, Von Schoultz E. Expression of syndecan-1 in paired samples of normal and malignant breast tissue from postmenopausal women. Anticancer Res 2007, 27(5A):3045-3050.
13. Ferguson JE, Schor AM, Howell A, Ferguson MW. Changes in the extracellular matrix of the normal human breast during the menstrual cycle. Cell Tissue Res 1992, 268(1):167-177. 10.1007/BF00338066, 1499048.
14. Longacre TA, Bartow SA. A correlative morphologic study of human breast and endometrium in the menstrual cycle. Am J Surg Pathol 1986, 10(6):382-393. 10.1097/00000478-198606000-00003, 3717495.
15. Ramakrishnan R, Khan SA, Badve S. Morphological changes in breast tissue with menstrual cycle. Mod Pathol 2002, 15(12):1348-1356. 10.1097/01.MP.0000039566.20817.46, 12481017.
16. Stoeckelhuber M, Stumpf P, Hoefter EA, Welsch U. Proteoglycan-collagen associations in the non-lactating human breast connective tissue during the menstrual cycle. Histochem Cell Biol 2002, 118(3):221-230.
17. Ma XJ, Dahiya S, Richardson E, Erlander M, Sgroi DC. Gene expression profiling of the tumor microenvironment during breast cancer progression. Breast Cancer Res 2009, 11(1):R7. 10.1186/bcr2222, 2687710, 19187537.
18. Schedin P, Borges V. Breaking down barriers: the importance of the stromal microenvironment in acquiring invasiveness in young women's breast cancer. Breast Cancer Res 2009, 11(2):102. 10.1186/bcr2235, 2688940, 19344495.
19. Barcellos-Hoff MH, Medina D. New highlights on stroma-epithelial interactions in breast cancer. Breast Cancer Res 2005, 7(1):33-36. 10.1186/bcr972, 1064117, 15642180.
20. Goldoni S, Seidler DG, Heath J, Fassan M, Baffa R, Thakur ML, Owens RT, McQuillan DJ, Iozzo RV. An antimetastatic role for decorin in breast cancer. Am J Pathol 2008, 173(3):844-855. 10.2353/ajpath.2008.080275, 2527080, 18688028.
21. Haslam SZ, Woodward TL. Host microenvironment in breast cancer development: epithelial-cell-stromal-cell interactions and steroid hormone action in normal and cancerous mammary gland. Breast Cancer Res 2003, 5(4):208-215. 10.1186/bcr615, 165024, 12817994.
22. Sunil N, Srinivasan N, Aruldhas MM, Govindarajulu P. Impact of oestradiol and progesterone on the glycosaminoglycans and their depolymerizing enzymes of the rat mammary gland. Acta Physiol Scand 2000, 168(3):385-392. 10.1046/j.1365-201x.2000.00675.x, 10712576.
23. Mennerich D, Vogel A, Klaman I, Dahl E, Lichtner RB, Rosenthal A, Pohlenz HD, Thierauch KH, Sommer A. Shift of syndecan-1 expression from epithelial to stromal cells during progression of solid tumours. Eur J Cancer 2004, 40(9):1373-1382. 10.1016/j.ejca.2004.01.038, 15177497.
24. Burbach BJ, Ji Y, Rapraeger AC. Syndecan-1 ectodomain regulates matrix-dependent signaling in human breast carcinoma cells. Exp Cell Res 2004, 300(1):234-247. 10.1016/j.yexcr.2004.07.001, 15383330.
25. Germeyer A, Klinkert MS, Huppertz AG, Clausmeyer S, Popovici RM, Strowitzki T, von Wolff M. Expression of syndecans, cell-cell interaction regulating heparan sulfate proteoglycans, within the human endometrium and their regulation throughout the menstrual cycle. Fertil Steril 2007, 87(3):657-663. 10.1016/j.fertnstert.2006.07.1526, 17123519.
26. Lai TH, King JA, Shih Ie M, Vlahos NF, Zhao Y. Immunological localization of syndecan-1 in human endometrium throughout the menstrual cycle. Fertil Steril 2007, 87(1):121-126. 10.1016/j.fertnstert.2006.06.042, 17113089.